Impact of the 2018 ASCO/CAP HER2 Guideline Focused Update Impact of the 2018 ASCO/CAP HER2 Guideline Focused Update

This study examined how the revised 2018 ASCO/CAP HER2 scoring criteria update impacted rates of HER2 equivocal and positive breast cancer diagnoses in a single institution.American Journal of Clinical Pathology

Source: Medscape Today Headlines - July 2, 2019 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news